PDCD4 deficiency improved 4-vinylcyclohexene dioxide-induced mouse premature ovarian insufficiency

What role does programmed cell death 4 (PDCD4) play in premature ovarian insufficiency (POI)? A PDCD4 gene knockout (PDCD4–/–) mouse model was constructed, a POI mouse model was established similar to human POI with 4-vinylcyclohexene dioxide (VCD), a PDCD4-overexpressed adenovirus was designed and...

Full description

Saved in:
Bibliographic Details
Published in:Reproductive biomedicine online Vol. 48; no. 4; p. 103685
Main Authors: Zhang, Jie, Qin, Mengzhen, Kao, Chunyu, Shi, Ying, Yang, Zhi, Chen, Tao, Liu, Minghao, Fang, Liang, Gao, Fei, Qin, Yingying, Ding, Lingling
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 01-04-2024
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:What role does programmed cell death 4 (PDCD4) play in premature ovarian insufficiency (POI)? A PDCD4 gene knockout (PDCD4–/–) mouse model was constructed, a POI mouse model was established similar to human POI with 4-vinylcyclohexene dioxide (VCD), a PDCD4-overexpressed adenovirus was designed and the regulatory role in POI in vitro and in vivo was investigated. PDCD4 expression was significantly increased in the ovarian granulosa cells of patients with POI (P ≤ 0.002 protein and mRNA) and mice with VCD-induced POI (P < 0.001 protein expression in both mouse ovaries and granulosa cells). In POI-induced mice model, PDCD4 knockouts significantly increased anti-Müllerian hormone, oestrodiol and numbers of developing follicles, and the PI3K-AKT-Bcl2/Bax signalling pathway is involved in it. The expression and regulation of PDCD4 significantly affects the POI pathology in a mouse model. This effect is closely related to the regulation of Bcl2/Bax and the activation of the PI3K-AKT signalling pathway.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1472-6483
1472-6491
1472-6491
DOI:10.1016/j.rbmo.2023.103685